6550--Rapid Molecular Testing via Roche Diagnostics Corporation 36C26025Q0839
Summary
AI-generated · Aug 25, 2025Rapid Molecular Testing supplies are requested for use at the Jonathan M. Wainwright Memorial VA to maintain the Roche Rapid Molecular Test System, including reagents and service, under a reagent rental agreement priced per test or per reportable result. The contract will be fixed-price for a base year plus four option years, covering testing of SARS-CoV-2, Influenza A/B, and Streptococcus Group A on clinical laboratory specimens.
The requirement remains focused on rapid molecular testing for SARS-CoV-2, Flu, and Strep, with a presolicitation issued and an award entry showing an award amount of $0.00, indicating no funded award amount has been established publicly yet.
RAPID MOLECULAR TESTING FOR SARS COV-2, FLU AND STREP
From Presolicitation posted on Aug 21, 2025Rapid Molecular Testing for SARS COV-2, Flu and STREP. The purpose of this activity is to acquire Rapid Molecular Testing Supplies for the Pathology and Laboratory Medical Service at the Jonathan M Wainwright Memorial VA. Maintain the use of the Rapid Molecular Test System, Reagents, and Service, for testing Clinical Laboratory specimens on a reagent rental agreement (Cost Per Test/Cost Per Reportable). Provide, and Service for performing SARS CoV-2, Influenza A/B and Strep Group A on a base year plus four (4) option years fixed price contract.
From Solicitation posted on Aug 21, 2025Notice history
2-
-
Solicitation Posted Aug 21, 2025View changes (3)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Set-Aside: None → No Set aside used
Details
Award Information
Contacts
Contracting Specialists
Agency
Place of Performance
USA